Insilico collaborates with Pfizer on novel data and AI system for target discovery

(InSilico Medicine) Insilico Medicine has entered into a research collaboration with Pfizer to utilize Insilico's machine learning technology and proprietary Pandomics Discovery Platform with the aim of identifying real-world evidence for potential therapeutic targets implicated in a variety of diseases.
Source: EurekAlert! - Biology - Category: Biology Source Type: news